Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results
Select data models

Selected data models

You must log in to select data models for download or further analysis.

4 Search results.

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Screening DRKS00004652 - Screening II

- 9/17/21 - 2 forms, 4 itemgroups, 41 items, 2 languages

Itemgroups: Basic data, Inclusion Criteria, Exclusion Criteria, Urine pregnancy test

Study documentation part: Screening. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Görge, University Hospital of Münster. EudraCT - Nr. 2012-000108-13.

Screening I

4 itemgroups 44 items

Examination_Riliva_CRF_EudraCT - Nr. 2012-000108-13 DRKS00004652 - Examination_Riliva_CRF_EudraCT - Nr. 2012-000108-13

- 3/15/21 - 1 form, 5 itemgroups, 59 items, 2 languages

Itemgroups: Vital Signs, skin examination, skin examination, LV - Score, skin examination Livedo racemosa

Study documentation part: Examination Week- 4, 8 and 12. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Grge, University Hospital of Mnster. EudraCT - Nr. 2012-000108-13.

Baseline Inspection_Riliva_CRF_EudraCT - Nr. 2012-000108-13 DRKS00004652 - Baseline Inspection_Riliva_CRF_EudraCT - Nr. 2012-000108-13

- 3/15/21 - 1 form, 5 itemgroups, 58 items, 2 languages

Itemgroups: Vital Signs, skin examination, skin examination, LV - Score, skin examination Livedo racemosa

Study documentation part: Baseline Inspection. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Görge, University Hospital of Münster. EudraCT - Nr. 2012-000108-13.

Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination DRKS00004652 - Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination

- 11/11/15 - 1 form, 1 itemgroup, 4 items, 2 languages

Itemgroup: Study termination

Study description: Study documentation part- Study termination. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Grge, University Hospital of Mnster. EudraCT - Nr. 2012-000108-13.

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.